First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina

Epidemiology and Infection
Juan Ignacio Degiuseppe, Juan Andrés Stupka

Abstract

Argentina incorporated rotavirus massive vaccination in 2015. No specific strategy has been designed to accurately measure the impact of this recent introduction on the diarrhoeal disease burden in our country. We assessed post-vaccine introduction data (all-cause acute diarrhoea and rotavirus laboratory-confirmed cases, and genotype distribution), compared with pre-vaccination period in children under 5 years of age in Argentina. Cross-sectional ecologic analysis was conducted with data from the Argentine Surveillance Health System. Endemic channel and global and seasonal incidence rates of pre- and post-vaccination periods were calculated and further compared. Conventional binary genotypification on rotavirus-positive samples was also performed. In post-vaccination period, a global decrease of 20.8% in the rate of all-cause acute diarrhoea cases was found. The endemic channel showed that declination was more significant in the autumn/winter season. Rotavirus laboratory-confirmed cases showed 61.7% of reduction and the weekly distribution analyses indicated a significant flattening of the expected seasonal peak. G2P[4] was the most prevalent circulating genotype (57.2%). This study represents the first assessment of diarrhoeal...Continue Reading

References

Jun 1, 1992·Journal of Clinical Microbiology·J R GentschM K Bhan
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jul 1, 1994·Journal of Clinical Microbiology·B K DasR I Glass
May 1, 1994·Journal of Clinical Microbiology·V GouveaM do C Timenetsky
Mar 2, 1999·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·M Bortman
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
Jun 8, 2007·Emerging Infectious Diseases·Sher Bahadur PunOsamu Nakagomi
Feb 9, 2008·Emerging Infectious Diseases·Ricardo Q GurgelCharles A Hart
Jan 29, 2010·The New England Journal of Medicine·Vesta RichardsonManish Patel
Jan 13, 2011·The Pediatric Infectious Disease Journal·Jennifer J HullUNKNOWN National Rotavirus Strain Surveillance System
Jan 12, 2011·The Pediatric Infectious Disease Journal·Lucia Helena de OliveiraJon Kim Andrus
May 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rishi DesaiUmesh D Parashar
Jul 4, 2012·Current Opinion in Virology·Ben A LopmanUmesh D Parashar
Jul 17, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A C B DulgheroffA L S Domingues
May 21, 2013·Health Devices
Mar 22, 2015·Vaccine·Emilie KarafillakisChristina Atchison
Oct 1, 2015·Revista Do Instituto De Medicina Tropical De São Paulo·Adriana LuchsMaria do Carmo Sampaio Tavares Timenetsky
Apr 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacqueline E TateUNKNOWN World Health Organization–Coordinated Global Rotavirus Surveillance Network
Aug 4, 2016·Journal of Medical Virology·Juan Ignacio DegiuseppeUNKNOWN Argentine Rotavirus Surveillance Network
Jul 19, 2017·Current Opinion in Infectious Diseases·Kulandaipalayam Natarajan Chella SindhuSanthosh Kumar Ganesan

❮ Previous
Next ❯

Citations

Jul 2, 2020·Pathogens·Meylin Bautista GutierrezTulio Machado Fumian
May 26, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Juan Ignacio DegiuseppeUNKNOWN Argentinean Rotavirus Surveillance Network

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Medical Virology
Juan Ignacio DegiuseppeArgentine Rotavirus Surveillance Network
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Lucia InchausteVolga Iñiguez
Bulletin of the World Health Organization
Umesh D ParasharRoger I Glass
© 2022 Meta ULC. All rights reserved